Header cover image

Norwegian (OSEAX) Biotech Industry Analysis

UpdatedFeb 03, 2023
DataAggregated Company Financials
Companies12
  • 7D4.2%
  • 3M6.5%
  • 1Y-42.2%
  • YTD-4.9%

In the last week, the Biotech industry is up 4.2%, with Nykode Therapeutics up 6.2%. In contrast, the industry has lost 42% in the last 12 months. In the next few years, earnings are forecast to decline by 7.2% annually.

Industry Valuation and Performance

Has the Norwegian Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 04 Feb 2023kr18.7bkr813.4m-kr1,396,596,585.0024x-13.4x23x
Mon, 02 Jan 2023kr19.2bkr804.9m-kr1,392,096,004.0039.4x-13.8x23.9x
Wed, 30 Nov 2022kr17.7bkr812.8m-kr1,396,305,402.0036.3x-12.7x21.8x
Fri, 28 Oct 2022kr17.5bkr799.8m-kr1,360,180,410.0033.6x-12.9x21.9x
Sun, 25 Sep 2022kr16.1bkr813.5m-kr1,364,650,805.0035.6x-11.8x19.8x
Tue, 23 Aug 2022kr21.4bkr777.0m-kr1,366,300,213.0039.3x-15.7x27.6x
Thu, 21 Jul 2022kr19.9bkr772.6m-kr1,381,826,129.0042.5x-14.4x25.7x
Sat, 18 Jun 2022kr19.5bkr1.1b-kr1,037,020,658.0042.3x-18.8x17.7x
Mon, 16 May 2022kr21.1bkr1.1b-kr1,012,638,822.0037.4x-20.9x19.4x
Wed, 13 Apr 2022kr25.0bkr1.1b-kr985,219,602.0041.7x-25.3x23.7x
Fri, 11 Mar 2022kr24.8bkr2.7bkr421.4m9x58.8x9.1x
Sun, 06 Feb 2022kr30.9bkr2.7bkr449.1m12.2x68.9x11.6x
Tue, 04 Jan 2022kr41.4bkr2.2bkr56.4m42.8x735.2x18.8x
Thu, 02 Dec 2021kr39.0bkr2.2bkr78.6m42.4x496.3x17.5x
Sat, 30 Oct 2021kr36.4bkr2.5bkr460.1m15.1x79.1x14.3x
Mon, 27 Sep 2021kr38.4bkr2.6bkr482.8m15.7x79.6x14.9x
Wed, 25 Aug 2021kr38.7bkr2.6bkr508.1m17x76.2x15x
Thu, 01 Jul 2021kr39.8bkr2.6bkr508.1m17.1x78.4x15.5x
Sun, 04 Apr 2021kr39.2bkr2.5bkr545.4m17.7x71.9x15.5x
Wed, 06 Jan 2021kr37.5bkr2.5bkr675.0m16.6x55.6x15x
Sat, 10 Oct 2020kr25.6bkr235.2m-kr1,189,469,577.0035.4x-21.5x108.7x
Fri, 03 Jul 2020kr21.9bkr252.5m-kr1,157,811,404.3320.2x-18.9x86.7x
Mon, 06 Apr 2020kr12.4bkr268.6m-kr1,101,468,269.7923.6x-11.3x46.3x
Price to Earnings Ratio

-11.7x


Total Market Cap: kr12.8bTotal Earnings: -kr1,101,022,953.96Total Revenue: kr233.9mTotal Market Cap vs Earnings and Revenue0%0%0%
Norwegian Biotech Industry Price to Earnings3Y Average 56.6x202120222023
Current Industry PE
  • Investors are pessimistic on the Norwegian Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 38.3x is higher than the industry's current PS ratio of 23.0x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 52% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the Norwegian Healthcare industry?

NO Market1.04%
Healthcare3.20%
Biotech4.20%
Biotech4.20%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NYKD Nykode Therapeuticskr32.8013.6%
+kr1.2b
-39.5%PS25.3x
ULTI Ultimovacskr125.009.3%
+kr364.6m
25.9%PB8.4x
BGBIO BerGenBiokr7.308.7%
+kr51.9m
-60.3%PS836.2x
AZT ArcticZymes Technologieskr41.900.6%
+kr12.1m
-48.9%PE64x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

AZT

kr41.90

ArcticZymes Technologies

7D

0.6%

1Y

-48.9%

EXTX

kr12.40

EXACT Therapeutics

7D

-4.6%

1Y

-34.7%

BGBIO

kr7.30

BerGenBio

7D

8.7%

1Y

-60.3%

ABS

kr11.00

Arctic Bioscience

7D

-0.9%

1Y

-31.3%

NANOV

kr0.92

Nordic Nanovector

7D

-9.9%

1Y

-93.3%

NYKD

kr32.80

Nykode Therapeutics

7D

13.6%

1Y

-39.5%

ULTI

kr125.00

Ultimovacs

7D

9.3%

1Y

25.9%

TRVX

kr1.03

Targovax

7D

-0.4%

1Y

-45.5%

PCIB

kr2.33

PCI Biotech Holding

7D

-22.9%

1Y

-63.7%